BackBioAffinity Technologies Overview

BioAffinity Technologies Total Liabilities

Latest total liabilities for BIAF: $3.9M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$3.85M
44.09% YoYΔ $-3.04M vs prior year quarter

Peer average

Loading

BioAffinity Technologies Total Liabilities History

Loading

BioAffinity Technologies vs. peers: Total Liabilities Comparison

Loading

BioAffinity Technologies Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

BioAffinity Technologies (BIAF) FAQ

BioAffinity Technologies (BIAF) currently reports a total liabilities of $3.9M as of June 2026. That compares with $6.9M in the prior-year period — down 44.1% year over year. Use the charts on this page to explore BioAffinity Technologies's total liabilities history and peer comparisons.

BioAffinity Technologies's total liabilities decreased from $6.9M to $3.9M — a 44.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BioAffinity Technologies reported $3.9M in total liabilities as of June 2026. That compares with $6.9M in the prior-year period — down 44.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $3.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioAffinity Technologies, and consider following BIAF for alerts when major investors trade the stock.